Pang, Swee Heng Milon http://orcid.org/0000-0001-7958-0244
D’Rozario, Joshua http://orcid.org/0000-0002-3380-4801
Mendonca, Senora
Bhuvan, Tejasvini
Payne, Natalie L. http://orcid.org/0000-0002-2045-2608
Zheng, Di
Hisana, Assifa
Wallis, Georgia
Barugahare, Adele http://orcid.org/0000-0002-8976-0094
Powell, David http://orcid.org/0000-0002-6639-6250
Rautela, Jai http://orcid.org/0000-0002-4253-9966
Huntington, Nicholas D. http://orcid.org/0000-0002-5267-7211
Dewson, Grant
Huang, David C. S. http://orcid.org/0000-0002-3101-4873
Gray, Daniel H. D. http://orcid.org/0000-0002-8457-8242
Heng, Tracy S. P. http://orcid.org/0000-0003-4147-8986
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1162499, 1107188)
Article History
Received: 4 November 2020
Accepted: 21 October 2021
First Online: 11 November 2021
Competing interests
: T.S.P.H. received funding from Mesoblast Ltd and Regeneus Ltd outside of this work. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication. N.D.H. and J.R. are founders and shareholders of oNKo-Innate Pty. Ltd, a discovery stage biotechnology company focussed on immuno-oncology, not related to this work. The remaining authors declare no competing interests.